Dr. Missak Haigentz, MD
Claim this profileRutgers Cancer Institute of New Jersey
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
14 reported clinical trials
23 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage I
Stage II
2Non-Small Cell Lung Cancer
Stage I
Stage II
Stage III
Affiliated Hospitals
Clinical Trials Missak Haigentz, MD is currently running
Chemotherapy + Immunotherapy
for Lung Cancer
The purpose of the research is to evaluate a new schedule of alternating cycles of induction chemoimmunotherapy (chemotherapy plus pembrolizumab) and immunotherapy (pembrolizumab) alone for the initial treatment of patients with advanced lung or head and neck cancers.
Recruiting1 award Phase 2
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
More about Missak Haigentz, MD
Clinical Trial Related4 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Missak Haigentz, MD has experience with
- Pembrolizumab
- Cisplatin
- Intensity-Modulated Radiation Therapy
- Paclitaxel
- 5Fluorouracil
- Carboplatin
Breakdown of trials Missak Haigentz, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Parotid Gland Cancer
Oropharyngeal Carcinoma
Neck Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
What does Missak Haigentz, MD specialize in?
Is Missak Haigentz, MD currently recruiting for clinical trials?
Are there any treatments that Missak Haigentz, MD has studied deeply?
What is the best way to schedule an appointment with Missak Haigentz, MD?
What is the office address of Missak Haigentz, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.